1. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
Antibacterials for acute bronchitis: yes or no? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
Influenza vaccination of healthy adults provides net savings |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
Potential chemotherapeutic target for trypanosomes identified |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 5-5
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
Breaking the mould: new directions in cancer vaccination |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 6-7
Allan Drew,
Preview
|
|
摘要:
The 92nd Annual Scientific Meeting of the American Association for Cancer Research [New Orleans, US; March 2001] provided an exceptional amount of data on investigational cancer vaccines. The effectiveness of vaccines in patients with a variety of malignancies was reported and important results on the efficacy of cancer vaccines in new patient groups were presented.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
Montelukast - creeping closer to the allergic rhinitis market |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 9-10
Deborah Cochrane,
Carmen Innes,
Preview
|
|
摘要:
Merck & Co.'s montelukast ['Singulair'] significantly reduces the symptoms of seasonal allergic rhinitis, according to new data presented at the 57th Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) [New Orleans, US; March 2001]. Two large studies presented at the meeting showed that the drug reduces daytime symptoms such as nasal congestion, rhinorrhoea, nasal itching and sneezing to a similar extent as Schering-Plough's antihistamine loratadine, and significantly more so than placebo. Other signs of seasonal allergic rhinitis such as night-time symptoms and daytime eye symptoms were also reduced by a significantly greater extent in montelukast and loratadine, compared with placebo, recipients. Moreover, a fixed combination of loratadine/montelukast was effective at reducing symptoms, but was not significantly better than montelukast or loratadine monotherapy. This is in contrast to data presented at the AAAAI meeting 3 years ago which showed the combination product was more effective than monotherapy with either drug.*
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
News in brief... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1285,
2001,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|